The primary aim of the study is to compare the effect of three different interventions on
lifestyle risk factors and biological risk factors for type 2 diabetes in depressed
Cambodians. The three different interventions are lifestyle, lifestyle plus medication
therapy management, and enhanced standard care.
Cambodian Americans have high risk for major depressive disorder and for type 2 diabetes.
Depression is a known risk factor for diabetes. Some antidepressants can also increase risk
of depression by causing weight gain. DREAM will test the effect of lifestyle and medication
therapy management (MTM) on diabetes risk among depressed Cambodian Americans. Community
health workers (CHWs) will deliver the lifestyle intervention and assist pharmacists with
MTM. Lifestyle and biological risk factors for diabetes, such as depressive symptoms and
insulin sensitivity, will be measured before and after the interventions.
- Self-identified as Cambodian or Cambodian-American
- Khmer speaking
- Major depressive disorder
- Elevated diabetes risk score per ADA guidelines
- >= 3 medications
- Competent to give consent.
- Pregnancy or plans to become pregnant in the next 2 years
- Previous diagnosis of diabetes
- Vision or hearing problems that would prevent participation in group sessions
- Currently being followed by a physician for major medical problem
- Currently being followed by a healthcare provider for major psychiatric problem other
Farmington, Connecticut 06030
Julie Wagner, PhD
Site Status: Recruiting